Jasper Therapeutics (JSPR) Revenue & Revenue Breakdown
Jasper Therapeutics Revenue Highlights
00
Jasper Therapeutics Revenue by Period
Jasper Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | - |
Jasper Therapeutics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Jasper Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | - | 100.00% |
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $1.17M | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $2.05M | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | - |
Jasper Therapeutics generated - in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Jasper Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| CELU | Celularity | $22.77M | $5.28M |
| GBIO | Generation Bio | $19.89M | $765.00K |
| VRCA | Verrica Pharmaceuticals | $7.57M | $14.34M |
| BTAI | BioXcel Therapeutics | $2.27M | $120.00K |
| SABS | SAB Biotherapeutics | $2.24M | - |
| QTTB | Q32 Bio | $1.16M | - |
| BOLD | Boundless Bio | - | - |
| NXTC | NextCure | - | - |
| MURA | Mural Oncology | - | - |
| JSPR | Jasper Therapeutics | - | - |
| PSTV | Plus Therapeutics | - | - |